Effects of alpha lipoic acid supplementation on some antioxidant defence system indices in patients with chronic renal failure undergoing hemodialysis.
Not Applicable
- Conditions
- Chronic renal failure undergoing hemodialysis.End-stage renal disease
- Registration Number
- IRCT138902041197N4
- Lead Sponsor
- utritional Research Center Tabriz University Of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 63
Inclusion Criteria
obtaining informed consent, being on HD for more than 6 months receiving 3 dialysis in week
Exclusion criteria: hepatitis and other infections, age less than 20 years, receiving any NSAID and SAID, alpha lipoic acid supplement, vitamin C , vitamin E, valproic acid in the last month, gastrointestinal disorders, candidate for kidney displacement, pregnancy, lactation, smoking, presence of any side effect
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method SOD. Timepoint: baseline and after 8 weeks. Method of measurement: Specrophotometery.;GPx. Timepoint: baseline and after 8 weeks. Method of measurement: Specrophotometery.;Catalase. Timepoint: baseline and after 8 weeks. Method of measurement: Specrophotometery.;Hb. Timepoint: baseline and after 8 weeks. Method of measurement: Specrophotometery.
- Secondary Outcome Measures
Name Time Method Health benefits for patients. Timepoint: baseline and weekly monitoring. Method of measurement: observation and evaluation of biochemical parameters.